General MedicationsORALStandard
CYCLOBENZAPRINE HYDROCHLORIDE
CYCLOBENZAPRINE HYDROCHLORIDE
Standard Dose
7.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CYCLOBENZAPRINE HYDROCHLORIDE is listed in Drugs@FDA under application 218936 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOBENZAPRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 7.5MG Sponsor RISING Submission history Latest submission status date: 2024-09-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYCLOBENZAPRINE HYDROCHLORIDE is listed in Drugs@FDA under application 218936 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOBENZAPRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 7.5MG Sponsor RISING Submission history Latest submission status date: 2024-09-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.